Redox‐responsive dual drug delivery nanosystem suppresses cancer repopulation by abrogating doxorubicin‐promoted cancer stemness, metastasis, and drug …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced …, 2019 - Wiley Online Library
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
Redox-Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin-Promoted Cancer Stemness, Metastasis, and Drug …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced Science …, 2019 - europepmc.org
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
[PDF][PDF] Redox-Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin-Promoted Cancer Stemness, Metastasis …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang, Z Wang… - Adv. Sci, 2019 - d-nb.info
Chemotherapy remains a major thera peutic approach for clinic oncotherapy. Although
cytotoxic chemotherapeutics bru tally kill cancer cells, cancer relapse still nearly inevitably …
cytotoxic chemotherapeutics bru tally kill cancer cells, cancer relapse still nearly inevitably …
[HTML][HTML] Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced …, 2019 - ncbi.nlm.nih.gov
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced …, 2019 - search.proquest.com
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
Redox-Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin-Promoted Cancer Stemness, Metastasis, and Drug …
J Liu, B Chang, Q Li, L Xu, X Liu… - Advanced science …, 2019 - pubmed.ncbi.nlm.nih.gov
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
Redox-Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin-Promoted Cancer Stemness, Metastasis, and Drug …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced Science …, 2019 - europepmc.org
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …